In recent years, the mental health and cognitive benefits of psilocybin have become increasingly evident. The new psychedelic revolution has put psilocybin mushrooms at the forefront of conversations regarding new, more effective treatments for depression, addiction, and many other mental issues. High doses can induce significant mind-altering experiences, which may be overwhelming for unprepared individuals. […]
Michael Pollan provides insights into the current psychedelic landscape. Minneapolis mayor unilaterally deprioritizes entheogen-related arrests. Synthetic psilocybin-assisted therapy shows promise in treating anorexia nervosa.
House committee blocks psychedelic amendments to a defense bill. Texan doctors want to investigate psychedelic psychotherapy’s effectiveness for late-stage cancer distress. Researchers have compared the brain activity of depressive patients on psilocybin vs. antidepressants.
Australia becomes a pioneer in psychedelic legalization. New study finds a link between microdosing and authenticity. The struggle to expand access to psychedelics continues in the U.S. Congress.
In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity and acceptance.
New study brings hope to cancer patients struggling with depressive symptoms. Conflicts in Kentucky commission developing plan to fund research on the benefits of ibogaine to treat opioid addiction. Ayahuasca played a key role in finding Colombian children stranded in the Amazonian jungle.
This week's psychedelic news include Rhode Island's psilocybin legalization push, a new psychedelic working group in Nevada, and more.
A new study shows how non-hallucinogenic psychedelics could be developed. Nevada also makes our psychedelic news list as it is is only steps away from creating its first interdisciplinary psychedelic working group.
In the world of psychedelic news, exciting developments are unfolding in the advancement of psychedelic research and policy.
